share_log

Moderna | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Sep 10 03:31
Summary by Futu AI
Moderna, Inc. officer Shannon Thyme is set to sell 551 shares of the company's common stock on 09/09/2024, according to a recent filing. The shares to be sold were acquired on 09/06/2024 as part of a restricted stock vesting and are considered compensation for Thyme's role at Moderna. The transaction is part of Thyme's regular stock trading plan and follows a series of sales over the past three months, where a total of 6,773 shares were sold.
Moderna, Inc. officer Shannon Thyme is set to sell 551 shares of the company's common stock on 09/09/2024, according to a recent filing. The shares to be sold were acquired on 09/06/2024 as part of a restricted stock vesting and are considered compensation for Thyme's role at Moderna. The transaction is part of Thyme's regular stock trading plan and follows a series of sales over the past three months, where a total of 6,773 shares were sold.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.